Literature DB >> 32038805

Noninvasive Monitoring of Bleomycin-induced Lung Injury in Rats Using Pulmonary Function Test.

Mi-Jin Yang1, Young-Su Yang1, Yong-Bum Kim1, Kyu-Hyuk Cho1, Jeong-Doo Heo1, Kyuhong Lee1, Chang-Woo Song1.   

Abstract

The single intratracheal instillation (ITI) of bleomycin (BLM) is a widely used method for inducing experimental pulmonary fibrosis in rat model. In the present study, pulmonary function tests (PFTs) of tidal volume (VT), minute volume (VM), and respiratory frequency (FR) have been applied to study their possibility as a tool to monitor the progress of BLM-induced lung injury in rat model. Rats were treated with a single ITI of BLM (2.5 mg/kg) or saline (control). Animals were euthanized at 3, 7, 14, 21, and 28 days post-ITI. Lung toxicity effects were evaluated by inflammatory cell count, lactate dehydrogenase (LDH) activity in the bronchoalveolar lavage fluid (BALF), and light microscopic examination of lung injury. The PFT parameters were measured immediately before the animals were sacrificed. BLM treatment induced significant cellular changes in BALF-increase in number of total cells, neutrophils, and lymphocytes along with sustained increase in number of macrophages compared to the controls at days 3, 7, and 14. BALF LDH level was significantly increased compared to that in the controls up to day 14. On day 3, infiltration of neutrophils was observed in the alveolar spaces. These changes developed into marked peribronchiolar and interstitial infiltration by inflammatory cells, and extensive thickening of the interalveolar septa on day 7. At 14, 21, and 28 days, mild peribronchiolar fibrosis was observed along with inflammatory cell infiltration. The results of PFT show significant consistencies compared to the results of other toxicity tests. These data demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days post-ITI of BLM based on the observation of fibrosis at 14, 21, and 28 days. Further, the progress of lung injury can be traced by monitoring the PFT parameters of FR, VT, and VM. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  Animal model; Bleomycin; Lung injury; Minute volume; Noninvasive monitoring; Pulmonary function; Respiratory frequency; Tidal volume

Year:  2008        PMID: 32038805      PMCID: PMC7006277          DOI: 10.5487/TR.2008.24.4.273

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  35 in total

1.  Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.

Authors:  Steven D Nathan; Oksana A Shlobin; Shahzad Ahmad; Susan Urbanek; Scott D Barnett
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

2.  Attenuation of bleomycin-induced lung fibrosis in rats by mesna.

Authors:  Azza El-Medany; Hanan H Hagar; Mahmoud Moursi; Raeesa At Muhammed; Fatma I El-Rakhawy; Gamila El-Medany
Journal:  Eur J Pharmacol       Date:  2005-01-21       Impact factor: 4.432

Review 3.  The role of pulmonary function testing in pulmonary fibrosis.

Authors:  K R Flaherty; F J Martinez
Journal:  Curr Opin Pulm Med       Date:  2000-09       Impact factor: 3.155

4.  Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats.

Authors:  J Cortijo; M Cerdá-Nicolás; A Serrano; G Bioque; J M Estrela; F Santangelo; A Esteras; A Llombart-Bosch; E J Morcillo
Journal:  Eur Respir J       Date:  2001-06       Impact factor: 16.671

5.  Suppression in lung defense responses after bacterial infection in rats pretreated with different welding fumes.

Authors:  James M Antonini; Michael D Taylor; Lyndell Millecchia; Alicia R Bebout; Jenny R Roberts
Journal:  Toxicol Appl Pharmacol       Date:  2004-11-01       Impact factor: 4.219

Review 6.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

Review 7.  Molecular mechanisms of pulmonary fibrosis and current treatment.

Authors:  K Kuwano; N Hagimoto; N Hara
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

8.  Indications for pulmonary function testing.

Authors:  V Lopez-Majano; G Renzi
Journal:  Respiration       Date:  1978       Impact factor: 3.580

9.  Halofuginone does not reduce fibrosis in bleomycin-induced lung injury.

Authors:  Anat Tzurel; Michael J Segel; Reuven Or; Ronald H Goldstein; Raphael Breuer
Journal:  Life Sci       Date:  2002-08-23       Impact factor: 5.037

10.  Bleomycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI.

Authors:  Harry Karmouty-Quintana; Catherine Cannet; Stefan Zurbruegg; François-Xavier Blé; John R Fozard; Clive P Page; Nicolau Beckmann
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.